BNP Paribas Financial Markets’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22M | Sell |
|
|||||
|
2025
Q2 | $22.5M | Buy |
|
|||||
|
2025
Q1 | $24.3M | Buy |
|
|||||
|
2024
Q4 | $27.1M | Buy |
|
|||||
|
2024
Q3 | $4.61M | Buy |
|
|||||
|
2024
Q2 | $4.01M | Buy |
|
|||||
|
2024
Q1 | $3.03M | Sell |
|
|||||
|
2023
Q4 | $10M | Sell |
|
|||||
|
2023
Q3 | $8.99M | Buy |
|
|||||
|
2023
Q2 | $5.34M | Sell |
|
|||||
|
2023
Q1 | $7.69M | Buy |
|
|||||
|
2022
Q4 | $1.87M | Sell |
|
|||||
|
2022
Q3 | $7.88M | Buy |
|
|||||
|
2022
Q2 | $907K | Buy |
|
|||||
|
2022
Q1 | $323K | Sell |
|
|||||
|
2021
Q4 | $706K | Buy |
|
|||||
|
2021
Q3 | $377K | Buy |
|
|||||
|
2021
Q2 | $146K | Sell |
|
|||||
|
2021
Q1 | $322K | Sell |
|
|||||
|
2020
Q4 | $462K | Sell |
|
|||||
|
2020
Q3 | $427K | Buy |
|
|||||
|
2020
Q2 | $238K | Sell |
|
|||||
|
2020
Q1 | $804K | Sell |
|
|||||
|
2019
Q4 | $1.58M | Buy |
|
|||||
|
2019
Q3 | $177K | Buy |
|
|||||
|
2019
Q2 | $102K | Sell |
|
|||||
|
2019
Q1 | $147K | Buy |
|
|||||
|
2018
Q4 | $40 | Sell |
|
|||||
|
2018
Q3 | $21K | Hold |
|
|||||
|
2018
Q2 | $26K | Sell |
|
|||||
|
2018
Q1 | $43.2K | Sell |
|
|||||
|
2017
Q4 | $48.8K | Buy |
|